We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$587M
AUM Growth
+$27M
Cap. Flow
-$4.79M
Cap. Flow %
-0.82%
Top 10 Hldgs %
19.31%
Holding
551
New
51
Increased
60
Reduced
107
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Financials 17.02%
3 Industrials 13.99%
4 Healthcare 11.28%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBGI icon
501
Beasley Broadcasting Group
BBGI
$37.8M
$104K 0.02%
+750
New +$119K
S
502
DELISTED
Sprint Corporation
S
$98K 0.02%
15,000
ACHN
503
DELISTED
Achillion Pharmaceuticals
ACHN
$92K 0.02%
25,000
-5,000
-17% -$14.9K
RMNI icon
504
Rimini Street
RMNI
$449M
$88K 0.02%
14,000
CHS
505
DELISTED
Chicos FAS, Inc.
CHS
$87K 0.01%
10,000
OMED
506
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$81K 0.01%
38,000
GERN icon
507
Geron
GERN
$828M
$79K 0.01%
45,000
-100,000
-69% -$436K
FSNN
508
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$77K 0.01%
30,000
ACTG icon
509
Acacia Research
ACTG
$428M
$64K 0.01%
20,000
-25,000
-56% -$93K
TIS
510
DELISTED
Orchids Paper Products, Inc.
TIS
$59K 0.01%
18,000
-30,000
-63% -$105K
WFT
511
DELISTED
Weatherford International plc
WFT
$54K 0.01%
20,000
BW icon
512
Babcock & Wilcox
BW
$1.39B
$44K 0.01%
4,325
-10,000
-70% -$166K
CLDX icon
513
Celldex Therapeutics
CLDX
$2.99B
$36K 0.01%
5,333
CYH icon
514
Community Health Systems
CYH
$393M
$35K 0.01%
10,000
CC icon
515
Chemours
CC
$2.5B
-5,000
Closed -$222K
CRUS icon
516
Cirrus Logic
CRUS
$6.53B
-10,000
Closed -$383K
CVGW
517
DELISTED
Calavo Growers
CVGW
-3,000
Closed -$288K
DIN icon
518
Dine Brands
DIN
$456M
-5,000
Closed -$374K
GNW icon
519
Genworth Financial
GNW
$3.76B
-120,000
Closed -$540K
IDCC icon
520
InterDigital
IDCC
$7.87B
-5,000
Closed -$405K
MYE icon
521
Myers Industries
MYE
$1.29B
-20,000
Closed -$384K
NKTR icon
522
Nektar Therapeutics
NKTR
$2.39B
-400
Closed -$293K
NRG icon
523
NRG Energy
NRG
$28.3B
-12,000
Closed -$368K
OII icon
524
Oceaneering
OII
$4.86B
-14,000
Closed -$356K
OLED icon
525
Universal Display
OLED
$3.68B
-5,000
Closed -$430K

Similar funds

NJ State Employees Deferred Compensation Plan's Q3 2018 Portfolio in Review

As of Q3 2018, NJ State Employees Deferred Compensation Plan held 551 positions worth $587M, up 4.8% from $560M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2018 filing shows 51 new, 60 increased, 107 reduced and 37 closed positions. Its largest new stake was AbbVie: 23,634 shares worth $2.23M. The largest sale was Apple, an estimated $3.12M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2018 buy was AbbVie: 23,634 shares worth $2.23M.
  • NJ State Employees Deferred Compensation Plan added most to Meta Platforms (Facebook) in Q3 2018, an estimated $1.63M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2018 reduction was Apple, cutting an estimated $3.12M.
  • NJ State Employees Deferred Compensation Plan fully exited U S Concrete, Inc. in Q3 2018, selling an estimated $840K.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 19% of its $587M portfolio in Q3 2018.
  • NJ State Employees Deferred Compensation Plan opened 51 new positions and closed 37 in Q3 2018.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 4.8% quarter-over-quarter to $587M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2018, filed 16 Oct 2018.